Ovarian Cancer Clinical Trials

Showing 881-900 of 1,169 trials

Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer

NCT01982500

Investigators propose to assess,the safety and tolerability profile (number of participants with adverse events) of bevacizumab (Avastin) when added to chemotherapy as front-line treatment of epithelial ovarian cancer, fallopian tube carcinoma or primary peritoneal carcinoma

Ovarian Cancer

Hellenic Oncology Research Group200 participantsStarted Mar 2012

Heraklion, Crete, Greece • Alexandroupoli, Greece • Athens, Greece +3 more locations

COMPLETEDPhase 2

Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer

NCT00408603

The purpose of this study is to evaluate the objective response rate, safety and identify potential biomarkers in platinum-resistant ovarian cancer patients treated with voreloxin injection given on a 28-day cycle.

Epithelial Ovarian Cancer

Sunesis Pharmaceuticals183 participantsStarted Dec 2006

Scottsdale, Arizona, United States • Newport Beach, California, United States • San Diego, California, United States +17 more locations

Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer

Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer

Related Searches

Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients

Pillars4Life Trial

CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors

A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission

Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer

Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)

Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer

A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed

AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites

Ovarian Cancer Vaccine for Patients in Remission

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Ensuring Communication in Hospice by Oncology Study (ECHO)

Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses